Essa Pharma Stock Today
| EPIX Stock | USD 1.62 0.01 0.61% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
ESSA Pharma is trading at 1.62 as of the 17th of March 2025; that is 0.61 percent decrease since the beginning of the trading day. The stock's open price was 1.63. ESSA Pharma has 45 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Essa Pharma is traded on NASDAQ Exchange in the United States.. The company has 44.39 M outstanding shares of which 678.18 K shares are currently shorted by private and institutional investors with about 2.81 trading days to cover. More on ESSA Pharma
Moving against ESSA Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ESSA Stock Highlights
| CEO and President and Director | David MD |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
ESSA Pharma (EPIX) is traded on NASDAQ Exchange in USA. It is located in 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 and employs 35 people. ESSA Pharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 71.91 M. ESSA Pharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 44.39 M outstanding shares of which 678.18 K shares are currently shorted by private and institutional investors with about 2.81 trading days to cover.
ESSA Pharma currently holds about 174.6 M in cash with (22.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ESSA Pharma Probability Of Bankruptcy
Ownership AllocationESSA Pharma holds a total of 44.39 Million outstanding shares. The majority of ESSA Pharma outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in ESSA Pharma to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in ESSA Pharma. Please pay attention to any change in the institutional holdings of ESSA Pharma as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ESSA Ownership Details
ESSA Pharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ESSA Pharma market risk premium is the additional return an investor will receive from holding ESSA Pharma long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0057 | |||
| Jensen Alpha | 0.0049 | |||
| Total Risk Alpha | 0.2451 | |||
| Treynor Ratio | (0.07) |
ESSA Stock Against Markets
ESSA Pharma Corporate Management
| Erin Rudsinski | Executive | Profile | |
| CMA CPA | Chief Officer | Profile | |
| Terry Schuenemeyer | Executive | Profile | |
| Neil Thapar | Executive | Profile | |
| Nkengyal Barber | Executive | Profile | |
| Alessandra MD | Chief Officer | Profile |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.